Table 10.
Retrospective study results, significant improvement in patients (see Table 4) versus reported results in double-blind, placebo-controlled studies of patients taking atomoxetine
Pilot study results |
Atomoxetine studies |
|||
---|---|---|---|---|
AA with OCT assay interpretation | Study 129 | Study 230 | Study 331 | |
n | 85 | 618 | 36 | 84 |
% improved | 77% (Table 4) | 71% | 54% | 59% |
% placebo improved | N/A | 28% | 40% | 31% |
% drug improvement over placebo | N/A | 43% | 14% | 28% |
Notes: The “% placebo improved” row represents percentage of subjects taking placebo who experienced significant remission of symptoms to the defined threshold of the study or greater. The bottom row is the advantage of the drug over placebo in the study cited.
Abbreviations: AA, amino acid; OCT, organic cation transporter.